PETER J GRAHAM
CIK 1235635 · Chief Legal Officer · last filed 2026-02-18
PETER J GRAHAM is a Chief Legal Officer who has filed 31 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing, for ADCT, was dated Feb 18, 2026. Across all open-market trades the lifetime net is −$206.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $827.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$827.4K
4
31
-$206.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADCT | Chief Legal Officer | 620,540 | $1.05 | $651.6K | $0 | 4 | 2026-02-18 |
| ANTARES PHARMA, INC. (ATRS) Delisted | EVP General Counsel, Secretary | 630,244 | $5.59 | $3.52M | -$206.2K | 20 | 2022-03-04 |
| DCTH | EVP; General Counsel | 15,000 | $11.72 | $175.8K | $0 | 5 | 2013-11-18 |
| E-Z-EM, Inc. (EZEM) Delisted | SVP - Chief Legal Officer | 0 | — | — | $0 | 1 | 2008-04-02 |
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-18 | ADCT | Mixed | +261,506 | $1.04M | EDGAR |
| 2025-12-09 | ADCT | Tax (F) | −49,508 | -$162.9K | EDGAR |
| 2025-02-14 | ADCT | Grant (A) | +220,000 | $354.2K | EDGAR |
| 2024-12-09 | ADCT | Tax (F) | −41,458 | -$129.8K | EDGAR |
| 2022-05-26 | — | Disp (D) | −740,843 | -$4.15M | |
| 2022-03-04 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +12,409 | -$51.8K | EDGAR |
| 2022-02-18 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +9,769 | -$48.7K | EDGAR |
| 2021-06-14 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +48,173 | $211.8K | EDGAR |
| 2021-06-10 | ANTARES PHARMA, INC. (ATRS) Delisted | Tax (F) | −15,996 | -$70.2K | EDGAR |
| 2021-03-03 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +21,837 | -$108.0K | EDGAR |